Huma receives 510(k) Class II clearance for its disease-agnostic platform
The FDA clearance comes just three months after the company received EU MDR Class IIb certification for its configurable disease management platform.
Stay updated with breaking news from Dan Vahdat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA clearance comes just three months after the company received EU MDR Class IIb certification for its configurable disease management platform.
The non-profit think tank Tony Blair Institute for Global Change earlier estimated that the post-Brexit investment levels in Britain are more than 30% lower than the pre- referendum trend.
The British economy has been the slowest to recover from COVID-19 of all Group of Seven nations and is the only one with a smaller workforce than before the pandemic.
NEW YORK and LONDON, June 12, 2023 /PRNewswire/ -- Huma Therapeutics ("Huma"), a leading global digital...
Huma's innovative approach to medical research cited in Lord James O'Shaughnessy's review for clinical trials improvement in the UKThe review is part of a new widespread policy approach to ignite